Ptc Therapeutics, Inc. · NASDAQ:PTCT

Almstead Neil Gregory sold 52,003 Ptc Therapeutics, Inc. shares (Form 4)

Traded Apr 1, 2026 · Filed Apr 3, 2026

On Apr 1, 2026, Almstead Neil Gregory (CHIEF TECHNICAL OPS OFFICER) sold 52,003 Ptc Therapeutics, Inc. shares at an average US$69.04 for US$3.59M under a trading plan, leaving 60,137 shares. Filed Apr 3, 2026 (Form 4).

Sold
52,003 shares
Price
US$69.04 average (US$68.89 to US$70.30)
Value
US$3.59M
Holding after
60,137 shares
Trading plan
Yes (Made under a plan set in advance)
Role
CHIEF TECHNICAL OPS OFFICER

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 1, 2026Common StockSale39,393US$68.8972,747Direct
Apr 1, 2026Common StockSale12,530US$69.5060,217Direct
Apr 1, 2026Common StockSale80US$70.3060,137Direct

Source

View original at SEC

Related